NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

I actually believe as a VP Duffy would be considered an officer of the company.

And beyond that, Innes is also a VP and his stock based compensation is reported. So it would serve to reason if Innes had to report securities included with his compensation, then Duffy would too.

Stock-based Compensation

During the six months ended June 30, 2019, the Company issued 200,000 shares of common stock to David Innes, the Company’s vice president investor relations pursuant to his employment agreement in February 2019. The Company recorded $48,000 stock-based compensation expense based on fair value on February 18, 2019, which was the effective date of his employment.

And Innes and Duffy were hired within the same fiscal year.

And Duffy wasn’t given any stock…either.